Editorial: Lung adenocarcinoma: from genomics to immunotherapy

Editorial: Lung adenocarcinoma: from genomics to immunotherapy

Bibliographic Details
Main Authors:	Yiming Meng, Maria Palmieri, Elisa Frullanti
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Genetics
Subjects:	solid cancer cancer biomarkers cancer prognosis disease monitoring lung cancer precision medicine
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2024.1399127/full

Similar Items

Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era
by: Maria Palmieri, et al.
Published: (2023-01-01)

Editorial: Current trends and future perspectives about liquid biopsy
by: Elisa Frullanti, et al.
Published: (2023-12-01)

Editorial: Pharmacogenetic landscape in human solid cancers
by: Elena Lastraioli, et al.
Published: (2024-01-01)

Commentary: Potential Links between Hepadnavirus and Bornavirus Sequences in the Host Genome and Cancer
by: Francesco Cetta, et al.
Published: (2018-07-01)

Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
by: Giovanna Maria Stanfoca Casagrande, et al.
Published: (2023-01-01)

Editorial: Impact of immunotherapy in lung cancer
by: Marion Ferreira, et al.
Published: (2022-11-01)

Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas
by: Elisa Dama, et al.
Published: (2020-12-01)

The landscape of actionable genomic alterations in lung adenocarcinomas in India
by: Rakesh Sharma, et al.
Published: (2023-12-01)

Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosisResearch in context
by: Xiaoshuang Feng, et al.
Published: (2023-06-01)

The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
by: Ismail Labgaa, et al.
Published: (2021-02-01)

Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy
by: Xian-Yang Qin, et al.
Published: (2023-04-01)

Diagnostic accuracy of circulating free DNA testing for the detection of KRAS mutations in non-small cell lung cancer: A systematic review and meta-analysis
by: Maria Palmieri, et al.
Published: (2022-10-01)

EFNA3 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in patients with lung adenocarcinoma
by: Mingming Deng, et al.
Published: (2021-10-01)

Screening and Identification of Key Genes for Clinical Benefit of Immunotherapy on Lung Adenocarcinoma Based on TCGA Database
by: QI Xiaoguang, et al.
Published: (2020-11-01)

Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer
by: Diletta Favero, et al.
Published: (2023-11-01)

Prognosis of metastasis based on age and serum analytes after follow-up of non-metastatic lung cancer patients
by: Murali Mohan Sagar Balla, et al.
Published: (2021-01-01)

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer
by: Qinglin Shen, et al.
Published: (2023-06-01)

Comprehensive analysis of gene expression and DNA methylation data identifies potential biomarkers and functional epigenetic modules for lung adenocarcinoma
by: XiaoCong Wang, et al.

Lung cancer organoids: models for preclinical research and precision medicine
by: Yajing Liu, et al.
Published: (2023-10-01)

Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
by: Maja Šutić, et al.
Published: (2021-10-01)

Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma
by: Hyun Woo Jeon, et al.
Published: (2022-09-01)

TIMP1 is an early biomarker for detection and prognosis of lung cancer
by: Ezequiel Dantas, et al.
Published: (2023-10-01)

Transcription Factor MAFB as a Prognostic Biomarker for the Lung Adenocarcinoma
by: Omar Samir, et al.
Published: (2022-09-01)

Editorial: Cancer genomics in the era of precision medicine
by: Omar M. Khan, et al.
Published: (2024-02-01)

RNA Biomarkers: Frontier of Precision Medicine for Cancer
by: Xiaochen Xi, et al.
Published: (2017-02-01)

OSluca: An Interactive Web Server to Evaluate Prognostic Biomarkers for Lung Cancer
by: Zhongyi Yan, et al.
Published: (2020-05-01)

m6A RNA Methylation Regulators Act as Potential Prognostic Biomarkers in Lung Adenocarcinoma
by: Hongbo Wang, et al.
Published: (2021-02-01)

Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis
by: Taiki Hakozaki, et al.
Published: (2022-11-01)

Identification of potential biomarkers for lung adenocarcinoma
by: Deepak Sayeeram, et al.
Published: (2020-11-01)

Editorial: Radiomics Advances Precision Medicine
by: Bo Gao, et al.
Published: (2022-03-01)

Immunotherapy Advances in Small Cell Lung Cancer
by: Yangyang XU, et al.
Published: (2020-11-01)

A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma
by: Guangxu Tu, et al.
Published: (2021-10-01)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
by: Dominik Andreas Barth, et al.
Published: (2020-08-01)

The effect of sarcopenia on erlotinib therapy in patients with metastatic lung adenocarcinoma
by: Atakan Topcu, et al.
Published: (2022-10-01)

The advances in immunotherapy biomarkers of small cell lung cancer
by: XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia
Published: (2021-07-01)

Progress in research on the role of fibrinogen in lung cancer
by: Liu Xing, et al.
Published: (2020-06-01)

Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer
by: Maria Adamaki, et al.
Published: (2021-01-01)

The characteristics and nomogram for primary lung papillary adenocarcinoma
by: Zhang Yuqian, et al.
Published: (2020-02-01)

Pulmonary adenocarcinoma possibly developed from the cut-end of small-sized adenocarcinoma in the lung periphery as recurrence 13 years after its wedge resection
by: Takaomi Hanaoka, et al.
Published: (2018-01-01)

Editorial: Immunotherapy and multimodality therapy for lung cancer
by: Chenghu Song, et al.
Published: (2024-01-01)